Skip to main content
. 2022 Jul 30;2022:5962195. doi: 10.1155/2022/5962195

Table 3.

Comparison of blood anti-PLA2R fluorescence intensity between stages II and III and stages I, IV, and V.

Group ± to + ++ to +++ Total
Stages I, IV, and V 42 0 42
Stages II and III 3 34 37
Total 45 34 79

x 2=68.76, p < 0.001.